News
28 May 2024
API production lines respectively for Gadoterate Meglumineand Cyclophosphamide passed the FDA on-site inspection.
In 2023, our API production lines respectively for Gadoterate Meglumineand Cyclophosphamide passed the FDA on-site inspection.
In 2023, our API production lines respectively for Gadoterate Meglumineand Cyclophosphamide passed the FDA on-site inspection.
Mentioned Companies
Anhui Poly Pharm Co.,Ltd
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance